Dimensional Fund Advisors

Dimensional Fund Advisors’s Enliven Therapeutics ELVN Stock Holding History

Dimensional Fund Advisors’s Portfolio ELVN Stock Details ELVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$26.7M	Buy	681,715 +282,822	+71%	+$7.84M	0.01%	1837
2025 Q4	$6.14M	Buy	398,893 +238,434	+149%	+$4.75M	﹤0.01%	2462
2025 Q3	$3.28M	Buy	160,459 +113,608	+242%	+$2.29M	﹤0.01%	2646
2025 Q2	$942K	Buy	+46,851	New	+$887K	﹤0.01%	2901
2023 Q3	–	Sell	-23,762	Closed	-$485K	–	3482
2023 Q2	$485K	Buy	23,762 +13,847	+140%	+$280K	﹤0.01%	3071
2023 Q1	$217K	Buy	9,915 +942	+10%	+$19.2K	﹤0.01%	3187
2022 Q4	$147	Buy	8,973 +1,907	+27%	+$30.5K	﹤0.01%	3279
2022 Q3	$64K	Buy	+7,066	New	+$41.7K	﹤0.01%	3377

Other funds holding ELVN

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return